Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

AC Immune (ACIU) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to 1721.62%.

  • AC Immune's EBITDA Margin fell 17501400.0% to 1721.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 1678.03%, marking a year-over-year decrease of 15399100.0%. This contributed to the annual value of 191.8% for FY2024, which is 1705000.0% up from last year.
  • As of Q3 2025, AC Immune's EBITDA Margin stood at 1721.62%, which was down 17501400.0% from 1484.53% recorded in Q2 2025.
  • In the past 5 years, AC Immune's EBITDA Margin ranged from a high of 18114.43% in Q1 2023 and a low of 862550.0% during Q1 2021
  • In the last 5 years, AC Immune's EBITDA Margin had a median value of 3051.09% in 2024 and averaged 57166.4%.
  • Per our database at Business Quant, AC Immune's EBITDA Margin tumbled by 2000000000bps in 2021 and then soared by 2000000000bps in 2022.
  • Quarter analysis of 5 years shows AC Immune's EBITDA Margin stood at 13171.68% in 2021, then soared by 80bps to 2655.82% in 2022, then crashed by -413bps to 13619.23% in 2023, then soared by 88bps to 1637.47% in 2024, then fell by -5bps to 1721.62% in 2025.
  • Its last three reported values are 1721.62% in Q3 2025, 1484.53% for Q2 2025, and 1956.57% during Q1 2025.